{
    "2019-10-04": [
        [
            {
                "time": "2023-10-01",
                "original_text": "A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Drug",
                        "Delayed",
                        "Stock",
                        "Cheering"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why This Biotech Stock Is Cheering A Potential Novartis Biosimilar Delay",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stock",
                        "Cheering",
                        "Novartis",
                        "Biosimilar",
                        "Delay"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Puma Biotech Gets FDA Nod of Labeling Supplement for Nerlynx",
                "features": {
                    "keywords": [
                        "Puma",
                        "Biotech",
                        "FDA",
                        "Nod",
                        "Labeling",
                        "Supplement",
                        "Nerlynx"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: JNJ's Opioid Settlement, FDA Updates for AZN, GSK, MRK, RHHBY",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "JNJ",
                        "Opioid",
                        "Settlement",
                        "FDA",
                        "Updates",
                        "AZN",
                        "GSK",
                        "MRK",
                        "RHHBY"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Here is Hedge Funds’ 30th Most Popular Stock Pick",
                "features": {
                    "keywords": [
                        "Hedge",
                        "Funds",
                        "Popular",
                        "Stock",
                        "Pick"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}